KALV vs MSFT: Which Stock is Better?
Side-by-side comparison of Kalvista Pharmaceuticals Inc and Microsoft Corp in 2026
KALV
Kalvista Pharmaceuticals Inc
$19.56
MSFT
Microsoft Corp
$419.69
Key Metrics Comparison
| Metric | KALV | MSFT | Winner |
|---|---|---|---|
| Market Cap | $1.07B | N/A | KALV |
| P/E Ratio | N/A | 25.70 | MSFT |
| EPS (TTM) | $N/A | $16.00 | MSFT |
| Revenue Growth | 0.3% | 0.2% | KALV |
| Gross Margin | 25.7% | 68.6% | MSFT |
Analyze KALV
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KALV or MSFT a better investment?
Comparing KALV and MSFT: Kalvista Pharmaceuticals Inc has a market cap of $1.07B while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KALV and MSFT?
KALV (Kalvista Pharmaceuticals Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KALV or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KALV or MSFT?
KALV has higher revenue growth at 0.3% vs 0.2% for MSFT.
Which company is more profitable: KALV or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 25.7% for KALV.
Which is the larger company: KALV or MSFT?
Kalvista Pharmaceuticals Inc (KALV) is larger with a market cap of $1.07B compared to N/A for MSFT.
Should I buy KALV or MSFT in 2026?
Both KALV and MSFT have investment merit. KALV trades at $19.56 while MSFT trades at $419.69. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KALV and MSFT stock?
Key differences: Market Cap ($1.07B vs N/A), P/E Ratio (N/A vs 25.7x), Revenue Growth (0.3% vs 0.2%), Gross Margin (25.7% vs 68.6%).